With Ultomiris, 9 items require prior approval for reimb.
By Lee, Hye-Kyung | translator Alice Kang
21.08.11 12:04:07
가나다라
0
No items were excluded since the introduction of the prior approval system…raises the need to change the system to a post review system
5,785 among the 6,001 applications that were filed last year were approved for reimbursement… 79 applications disapproved
Improvements are expected to be made to the ‘pre-approval' system that may be actively used in the process of reimbursement listings for ultra-high-priced drugs.
Starting with the stem cell transplantation procedure in 1992, the Health Insurance Review and Assessment Service (HIRA) has been operating the pre-approval system to deliberate in advance whether an insurance benefit should be applied to high-risk, high-cost, irreplaceable drugs and procedures.
With the most recent addition of ‘'Ultomiris inj.,’ a total of 9 items are on the list for deliberation for pre-approval of insurance benefits. The other 8 include ▲ Stem Cell Transplantation; ▲ Immune Tolerance Induction; ▲Soliris Inj
Lee, Hye-Kyung(hgrace7@dailypharm.com)
If you want to see the full article, please JOIN US (click)